PubMed HealthSearch

Biomedical subjects

G W Poole

Publications and source records attributed to G W Poole.

3 recordsLinked to original sources

Abnormal calcium metabolism in normocalcaemic sarcoidosis.

In studies of calcium metabolism in 13 unselected patients with untreated sarcoidosis all were normocalcaemic but five had hypercalcuria. All had normal renal function. Calcium absorption was indexed by a double isotope test. 45Ca hyperabsorption occurred in six patients. Ten kinetic studies were carried out with 47Ca and in six bone turnover was increased. 45Ca absorption correlated well with the calculated bone uptake rate of calcium, and with urine calcium excretion. These results suggest that in sarcoidosis abnormalities in calcium metabolism are fairly common although they rarely result in sustained hypercalcaemia.

Adult

Validation of continuous determination of respired gases during steady-state exercise.

A continuous-flow sampling system (CFS) for convenient and rapid determination of respiratory gas exchange during steady-state exercise was described. CFS was compared to the classical bag collection system (BCS) by utilizing both methods concurrently during exercise for analysis of 32 1-min gas samples. The gas collected by BCS was analyzed by chemical absorption. The error in the gas mixing and sampling technique of CFS contributed to the absolute error of the gas analysis but did not adversely affect the reliability. The linear regression analysis on the data suggests that CFS is a relatively accurate and reliable system for use at light and moderate levels of steady-state work. However, it is hypothesized that unsteady-state conditions and heavy exercise, which elicits high ventilation rates, would compromise the accuracy and reliability of CFS. Therefore, it is recommended that the traditional BCS be utilized for determination of maximal oxygen uptake.

Carbon Dioxide

111-In-labelled bleomycin; clinical experience as a diagnostic agent in tumours of the thorax and abdomen.

The potential value of indium-labelled bleomycin as a diagnostic scanning agent has been investigated in patients with a variety of malignant neoplasms involving the thorax, abdomen or pelvis. Sixty-five patients were scanned on 72 occasions, the optimum time to perform the examination being 72 hours after the intravenous injection of 2 mCi 111-In chelated to 2 mg bleomycin. Tumour uptake was visualized in 53 out of 62 scans in which tumour was present, but the extent of tumour was underestimated in seven cases, and over-estimated in five others. The latter were mostly due to uptake in infective lesions. These results indicate that the situations in which indium bleomycin is most likely to provide clinically relevant information are the distinction between recurrent tumour and post-radiotherapy changes in the thorax and pelvis, the diagnosis of recurrent carcinoma within the pelvis, and the distinction between bony metastases from carcinoma of the prostate and Paget's disease. Further clinical trials are necessary to assess these situations.

Abdominal Neoplasms